Vaso Corporation (VASO)
Stock Price:
$0.0238 USD
0.0040 (19.00%)
Updated Oct 20, 2020 3:02 PM EDT - Market closed
Key Info
| Market Cap |
4.16M |
| Revenue (ttm) |
76.30M |
| Net Income (ttm) |
1.67M |
| Shares Out |
174.72M |
| EPS (ttm) |
0.01 |
| PE Ratio |
2.38 |
| Forward PE |
n/a |
| Dividend |
n/a |
| Dividend Yield |
n/a |
Stock Quote
| Trading Day |
Oct 20, 2020 |
| Last Price |
$0.0238 |
| Previous Close |
$0.0200 |
| Change ($) |
0.0040 |
| Change (%) |
19.00% |
| Day's Open |
0.0200 |
| Day's Range |
0.0200 - 0.0240 |
| Day's Volume |
39,561 |
| 52-Week Range |
0.01 - 0.04 |
More Stats
| Market Cap |
4.16M |
| Enterprise Value |
11.09M |
| Earnings Date (est) |
n/a |
| Ex-Dividend Date |
n/a |
| Shares Outstanding |
174.72M |
| Float |
97.00M |
| EPS (basic) |
0.01 |
| EPS (diluted) |
0.01 |
| FCF / Share |
0.02 |
| Dividend |
n/a |
| Dividend Yield |
n/a |
| Earnings Yield |
42.02% |
| FCF Yield |
99.56% |
| Payout Ratio |
n/a |
| Shares Short |
n/a |
| Short Ratio |
n/a |
| Short % of Float |
n/a |
| Beta |
2.28 |
| PE Ratio |
2.38 |
| Forward PE |
n/a |
| P/FCF Ratio |
1.00 |
| PS Ratio |
0.05 |
| PB Ratio |
0.88 |
| Revenue |
76.30M |
| Operating Income |
2.40M |
| Net Income |
1.67M |
| Free Cash Flow |
4.14M |
| Net Cash |
-6.93M |
| Net Cash / Share |
-0.04 |
| Gross Margin |
55.91% |
| Operating Margin |
3.15% |
| Profit Margin |
2.20% |
| FCF Margin |
5.43% |
| ROA |
3.27% |
| ROE |
54.38% |
| ROIC |
43.80% |
Stats based on trailing-twelve-month (ttm) numbers.
Analyst Summary
Analyst Ratings (0)
| Buy |
0 |
| Overweight |
0 |
| Hold |
0 |
| Underweight |
0 |
| Sell |
0 |
*No analysts have provided price targets for this stock.
Financial Performance
Financial numbers in millions USD.
Financial Overview
| Year | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 |
|---|
| Revenue | 75.75 | 73.98 | 72.79 | 72.59 | 57.08 | 34.95 | 32.89 | 29.24 | 16.37 | 4.21 |
| Revenue Growth | 2.39% | 1.64% | 0.27% | 27.17% | 63.31% | 6.28% | 12.48% | 78.59% | 289.28% | - |
| Gross Profit | 42.66 | 41.12 | 40.73 | 41.50 | 35.37 | 25.19 | 22.51 | 20.59 | 10.91 | 2.21 |
| Operating Income | 1.01 | -3.72 | -3.83 | 1.56 | 3.94 | 1.06 | -1.29 | -3.51 | -3.93 | -1.98 |
| Net Income | 0.04 | -3.73 | -4.54 | 0.82 | 3.82 | 1.13 | -1.15 | -3.38 | -3.89 | -1.89 |
| Shares Outstanding | 168 | 165 | 162 | 159 | 157 | 155 | 159 | 158 | 112 | 102 |
| Earnings Per Share | - | -0.02 | -0.03 | 0.01 | 0.02 | 0.01 | -0.01 | -0.02 | -0.04 | -0.02 |
| EPS Growth | - | - | - | -50% | 100% | - | - | - | - | - |
| Operating Cash Flow | -1.33 | -1.45 | 1.60 | 5.22 | 6.52 | 2.59 | -1.50 | 9.43 | 4.14 | -1.59 |
| Capital Expenditures | -1.18 | -2.59 | -2.37 | -1.87 | -0.89 | -0.37 | -0.23 | -0.40 | -0.14 | -0.03 |
| Free Cash Flow | -2.52 | -4.04 | -0.78 | 3.35 | 5.63 | 2.23 | -1.73 | 9.03 | 4.00 | -1.61 |
| Cash & Equivalents | 2.12 | 2.67 | 5.25 | 7.09 | 2.16 | 9.24 | 8.07 | 11.58 | 8.24 | 0.55 |
| Total Debt | 13.55 | 10.53 | 8.85 | 9.83 | 7.33 | 0.16 | - | - | - | 1.25 |
| Net Cash / Debt | -11.43 | -7.86 | -3.61 | -2.74 | -5.17 | 9.08 | 8.07 | 11.58 | 8.24 | -0.70 |
| Assets | 54.36 | 50.47 | 56.78 | 57.38 | 50.42 | 40.99 | 33.52 | 32.38 | 18.55 | 3.86 |
| Liabilities | 48.58 | 44.86 | 47.63 | 44.47 | 38.68 | 33.24 | 27.05 | 23.37 | 15.65 | 3.43 |
| Book Value | 5.79 | 5.61 | 9.15 | 12.91 | 11.74 | 7.75 | 6.47 | 9.01 | 2.91 | 0.43 |
Numbers in millions USD, except per-share numbers.
Company Details
| Full Name |
Vaso Corporation |
| Country |
United States |
| Employees |
294 |
| CEO |
Jun Ma |
Stock Information
| Ticker Symbol |
VASO |
| Stock Exchange |
US OTC |
| Sector |
Healthcare |
| Industry |
Health Information Services |
| Unique Identifier |
OTCMKTS: VASO |
| IPO Date |
October 24, 1988 |
Description
Vaso Corporation, together with its subsidiaries, operates in the healthcare equipment and information technology industries in the United States and internationally. The company operates through three segments: IT, Professional Sales Service, and Equipment. The IT segment primarily focuses on healthcare IT and managed network technology services. This segment offers managed diagnostic imaging applications, managed network infrastructure, managed network transport, and managed security services. The Professional Sales Service segment principally focuses on the sale of healthcare capital equipment for General Electric Healthcare (GEHC) into the health provider middle market. Its offerings include GEHC diagnostic imaging capital equipment, GEHC service agreements, and GEHC and third party financial services. The Equipment segment primarily focuses on the design, manufacture, sale, and service of proprietary medical devices. This segment provides Biox series Holter monitors and ambulatory blood pressure recorders; ARCS series analysis, reporting, and communication software for physiological signals, such as ECG and blood pressure; MobiCare multi-parameter wireless vital-sign monitoring systems; and Enhanced External Counterpulsaion therapy systems that are used for non-invasive, outpatient treatment of ischemic heart disease, as well as in-service training support. The company was formerly known as Vasomedical, Inc. and changed its name to Vaso Corporation in November 2016. The company was founded in 1987 and is headquartered in Plainview, New York.